409 related articles for article (PubMed ID: 37549657)
41. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
42. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
[TBL] [Abstract][Full Text] [Related]
43. Nanoparticles containing insoluble drug for cancer therapy.
Guo S; Huang L
Biotechnol Adv; 2014; 32(4):778-88. PubMed ID: 24113214
[TBL] [Abstract][Full Text] [Related]
44. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective.
Zhang J; Jiao J; Niu M; Gao X; Zhang G; Yu H; Yang X; Liu L
Int J Nanomedicine; 2021; 16():6497-6530. PubMed ID: 34588777
[TBL] [Abstract][Full Text] [Related]
45. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
Maurya S; Srivastava R; Arfin S; Hawthorne S; Jha NK; Agrawal K; Raj S; Rathi B; Kumar A; Raj R; Agrawal S; Paiva-Santos AC; Malik AA; Dua K; Rana R; Ojha S; Jha SK; Sharma A; Kumar D; El-Zahaby SA; Nagar A
Nanomedicine (Lond); 2022 Dec; 17(30):2245-2264. PubMed ID: 36975758
[TBL] [Abstract][Full Text] [Related]
46. Nano-drug delivery system for the treatment of acute myelogenous leukemia.
Zhang S; Sun J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):233-240. PubMed ID: 35713321
[TBL] [Abstract][Full Text] [Related]
47. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
Miller-Kleinhenz JM; Bozeman EN; Yang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
[TBL] [Abstract][Full Text] [Related]
48. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
49. Nano-formulations of drugs: Recent developments, impact and challenges.
Jeevanandam J; Chan YS; Danquah MK
Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
[TBL] [Abstract][Full Text] [Related]
50. Advances and challenges in nanocarriers and nanomedicines for veterinary application.
Carvalho SG; Araujo VHS; Dos Santos AM; Duarte JL; Silvestre ALP; Fonseca-Santos B; Villanova JCO; GremiĆ£o MPD; Chorilli M
Int J Pharm; 2020 Apr; 580():119214. PubMed ID: 32165220
[TBL] [Abstract][Full Text] [Related]
51. Medical and dental applications of nanomedicines.
Kavoosi F; Modaresi F; Sanaei M; Rezaei Z
APMIS; 2018 Oct; 126(10):795-803. PubMed ID: 30264432
[TBL] [Abstract][Full Text] [Related]
52. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
53. Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine.
Kumar V; Rahman M; Gahtori P; Al-Abbasi F; Anwar F; Kim HS
Expert Opin Drug Deliv; 2021 Jun; 18(6):673-694. PubMed ID: 33295218
[TBL] [Abstract][Full Text] [Related]
54. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
55. Engineered therapeutic proteins for sustained-release drug delivery systems.
Nguyen TTK; Pham KY; Yook S
Acta Biomater; 2023 Nov; 171():131-154. PubMed ID: 37717712
[TBL] [Abstract][Full Text] [Related]
56. Nanotechnology based targeted drug delivery.
Ruggiero C; Pastorino L; Herrera OL
Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():3731-2. PubMed ID: 21096863
[TBL] [Abstract][Full Text] [Related]
57. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
58. Recent advances on drug delivery nanocarriers for cerebral disorders.
Zhou Z; Sun T; Jiang C
Biomed Mater; 2021 Feb; 16(2):024104. PubMed ID: 33455956
[TBL] [Abstract][Full Text] [Related]
59. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
60. Managing Apoptosis in Lung Diseases using Nano-assisted Drug Delivery System.
Shukla MK; Dubey A; Pandey S; Singh SK; Gupta G; Prasher P; Chellappan DK; Oliver BG; Kumar D; Dua K
Curr Pharm Des; 2022; 28(39):3202-3211. PubMed ID: 35422206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]